Biocure Technology Inc.
CUREX
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -176.30K | -175.50K | -188.70K | -2.99M | -3.06M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.10K | 5.90K | 5.70K | 2.89M | 2.96M |
| Change in Net Operating Assets | 116.10K | 171.80K | 193.20K | 142.60K | 153.00K |
| Cash from Operations | -54.20K | 2.10K | 10.20K | 52.30K | 49.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -47.00K | -47.00K |
| Issuance of Common Stock | 100.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -3.00K | -3.00K |
| Cash from Financing | 72.30K | -- | -- | -36.80K | -36.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.10K | 2.10K | 10.20K | 15.60K | 12.60K |